Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 15.01M | 15.01M | 25.39M | 21.88M | 18.36M | 11.77M |
Gross Profit | 6.40M | 6.40M | 19.04M | 21.20M | 16.62M | 11.22M |
EBITDA | 3.29M | 738.00K | 28.47M | 0.00 | -1.72M | 0.00 |
Net Income | 2.00M | 2.00M | 11.61M | 19.59M | 20.39M | 13.95M |
Balance Sheet | ||||||
Total Assets | 268.60M | 268.60M | 238.31M | 221.52M | 183.73M | 105.91M |
Cash, Cash Equivalents and Short-Term Investments | 19.77M | 19.77M | 36.26M | 41.73M | 26.54M | 15.96M |
Total Debt | 88.33M | 88.33M | 70.88M | 55.07M | 48.85M | 18.13M |
Total Liabilities | 91.05M | 91.05M | 73.03M | 57.26M | 50.79M | 20.13M |
Stockholders Equity | 177.55M | 177.55M | 165.28M | 164.26M | 132.94M | 85.79M |
Cash Flow | ||||||
Free Cash Flow | 10.28M | 21.52M | 16.92M | 10.72M | 71.92M | 9.40M |
Operating Cash Flow | 17.16M | 21.52M | 16.92M | 10.72M | 9.34M | 7.53M |
Investing Cash Flow | -22.87M | -22.87M | -26.38M | -25.17M | -61.83M | -8.42M |
Financing Cash Flow | 22.69M | 18.33M | -2.75M | 17.71M | 56.49M | -1.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $17.46B | 11.65 | 10.44% | 3.86% | 10.36% | 1.15% | |
57 Neutral | 65.56 | 1.17% | 9.49% | -2.74% | -82.86% | ||
47 Neutral | £1.47M | ― | -34.06% | ― | ― | 80.00% | |
44 Neutral | £2.73M | ― | -71.01% | ― | ― | ― | |
43 Neutral | £1.77M | ― | -38.03% | ― | -100.24% | 84.97% | |
38 Underperform | £443.01K | ― | -224.82% | ― | ― | ― |
Duke Capital Limited announced the successful passing of all resolutions at its recent Annual General Meeting, indicating strong shareholder support for its strategic direction. This development reinforces Duke’s position in the market as a reliable provider of hybrid capital solutions, potentially enhancing its operational capabilities and stakeholder confidence.
The most recent analyst rating on (GB:DUKE) stock is a Buy with a £41.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited has announced the approval of 4,663,000 conditional rights to acquire ordinary shares under its Long-Term Incentive Plan (LTIP) for the financial year ending March 2025. The performance share awards (PSAs) will vest over three years, contingent on performance conditions related to shareholder return and cash distribution per share. Additionally, 1,318,233 PSAs from the 2022 financial year have vested, with some shares sold to cover tax liabilities. This move underscores Duke Capital’s commitment to aligning employee incentives with company performance, potentially enhancing its market position and shareholder value.
The most recent analyst rating on (GB:DUKE) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited has announced the release of its 2025 Annual Report and Accounts, along with the Notice of its Annual General Meeting (AGM), which will be held on August 4, 2025, in Guernsey. This announcement underscores Duke Capital’s commitment to transparency and shareholder engagement, reflecting its strategic focus on delivering attractive risk-adjusted returns and maintaining robust communication with its stakeholders.
The most recent analyst rating on (GB:DUKE) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited reported its financial results for the year ending March 31, 2025, demonstrating resilience and strategic execution amid challenging economic conditions. The company saw a 6% increase in recurring cash revenue but experienced a decrease in total cash revenue and net income due to a lack of investment exits and a non-cash reduction in portfolio value. Despite these challenges, Duke maintained a stable dividend and robust liquidity position, underscoring its disciplined capital allocation and income-generating model. The company made significant follow-on investments in existing partners, enhancing its portfolio’s value and supporting M&A activities. Looking forward, Duke Capital anticipates improved conditions with easing inflation and interest rates, which could enhance its attractiveness to investors.
The most recent analyst rating on (GB:DUKE) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited announced an interim dividend of 0.70 pence per share for the first quarter of its financial year, reflecting its commitment to providing attractive returns to shareholders. This decision underscores Duke’s strategic focus on capital preservation and dividend yield, reinforcing its market position as a reliable provider of hybrid capital solutions for SMEs in Europe and North America.
The most recent analyst rating on (GB:DUKE) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited has announced a follow-on investment of £2.0 million into Tristone Healthcare Limited to support its acquisition of Serenity Care Homes Limited, a specialist in therapeutic care for young individuals. This investment increases Duke’s total credit financing in Tristone to £21.2 million and raises its ownership stake to 28.4%. The acquisition will enable Tristone to expand its services for young adults with complex needs in the South of England, enhancing its regional partnerships and reputation for high-quality care. This strategic move is expected to extend Tristone’s reach in the social care sector, employing over 800 staff members.
The most recent analyst rating on (GB:DUKE) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited has announced that it will release its audited results for the fiscal year ending March 31, 2025, on June 25, 2025. Additionally, the company will host a live investor presentation on June 30, 2025, where CEO Neil Johnson and CFO Hugo Evans will discuss the results. This presentation is open to all existing and potential shareholders, providing an opportunity for stakeholders to engage with the company’s leadership and gain insights into its financial performance and strategic direction.
The most recent analyst rating on (GB:DUKE) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.